SCHEMBL6715271

SCHEMBL6715271

CCCCC(C)(Cc1ccc(O)cc1)C(=O)OCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 10/20 0.44
ESR2 Q92731 5/20 0.44
BLM P54132 1/20 0.42
MMP8 P22894 1/20 0.42
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA7 P43166 2/20 0.41
CA9 Q16790 2/20 0.41
CA14 Q9ULX7 2/20 0.41
TSHR P16473 3/20 0.41
LMNA P02545 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
MAPK1 P28482 1/20 0.41
CYP2C19 P33261 1/20 0.41
NR1H2 P55055 1/20 0.41
RNASEL Q05823 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
SLC6A2 P23975 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6713541 0.85 MMP8 (0.49) ESR1ESR2BLMMMP8LMNA
SCHEMBL6713635 0.82 L3MBTL1 (0.50) MMP8LMNAALDH1A1KDM4EPPARG
SCHEMBL28106001 0.82 BLM (0.54) ESR1ESR2BLMTSHRLMNA
SCHEMBL6715300 0.82 PPARA (0.45) LMNACYP1A2CYP2D6MAPK1SMN1; SMN2
SCHEMBL6714902 0.81 PPARA (0.44) LMNACYP1A2CYP2D6MAPK1SMN1; SMN2
SCHEMBL8486868 0.79 ESR1 (0.50) ESR1ESR2BLMMMP8CA12
SCHEMBL27924507 0.78 CYP4F2 (0.48) MMP8CA1CA2TSHRLMNA
SCHEMBL6717544 0.77 PPARA (0.46) LMNACYP1A2CYP2D6MAPK1SMN1; SMN2
SCHEMBL20507235 0.77 PTPRB (0.45) MMP8TSHRLMNACYP1A2CYP2C19
SCHEMBL3993833 0.77 ESR1 (0.48) ESR1ESR2BLMMMP8CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040006141-A1 Amidocarboxylic acid compounds SANKYO COMPANY, LTD (JP) 2004-01-08 US disclosed
US-6528525-B1 Amidocarboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-03-04 US disclosed
CN-1280561-A Amidocarboxylic acid derivatives SANKYO CO (JP) 2001-01-17 CN disclosed
EP-1026149-A1 AMIDOCARBOXYLIC ACID DERIVATIVES Sankyo Company Limited (JP) 2000-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006141-A1 Amidocarboxylic acid compounds NR1H2, AGK, APOL1 ESR1 588/4885ESR2 354/4885BLM 2979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.